5-Methoxy-2-tetralone: A Cornerstone Intermediate for Dopamine Agonists
NINGBO INNO PHARMCHEM CO.,LTD. is a leading supplier of essential chemical intermediates, and 5-Methoxy-2-tetralone (CAS 32940-15-1) is a prime example of a compound with high strategic importance in pharmaceutical synthesis. Its role as a cornerstone intermediate for dopamine agonists, particularly Rotigotine, highlights its value in modern medicine.
5-Methoxy-2-tetralone, with its molecular formula C11H12O2 and molecular weight of 176.21, is a yellowish-orange solid that serves as a critical pharmaceutical intermediate. Its primary use is in the complex synthesis of Rotigotine, a medication vital for managing Parkinson's disease. As a precursor to dopamine agonists, this compound is fundamental for neurological treatment development. The reliability of 5-methoxy-2-tetralone suppliers directly impacts the continuity of these life-improving drug productions.
The chemical industry relies on precise manufacturing processes, and the consistent quality of intermediates like 5-Methoxy-2-tetralone is paramount. NINGBO INNO PHARMCHEM CO.,LTD. ensures that our product meets the stringent requirements for its application as a Rotigotine synthesis intermediate. By providing access to high-purity materials, we support the development and large-scale production of dopamine agonist intermediate compounds and their derivatives.
As a supplier of specialty pharmaceutical synthesis chemicals, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to facilitating the creation of advanced therapeutic solutions. 5-Methoxy-2-tetralone is a key enabler in this mission, contributing significantly to the fight against neurological disorders.
Perspectives & Insights
Chem Catalyst Pro
“Its primary use is in the complex synthesis of Rotigotine, a medication vital for managing Parkinson's disease.”
Agile Thinker 7
“As a precursor to dopamine agonists, this compound is fundamental for neurological treatment development.”
Logic Spark 24
“The reliability of 5-methoxy-2-tetralone suppliers directly impacts the continuity of these life-improving drug productions.”